We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 325

Time is running out for FDA's online and social media advertising guidance

  • Reed Smith LLP
  • -
  • USA
  • -
  • May 23 2013

Thomas Abrams, director of the Food and Drug Administration (FDA) Office of Prescription Drug Promotion, recently indicated that long-awaited draft

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

  • Bird & Bird
  • -
  • Sweden
  • -
  • May 22 2013

This article is a follow-up to an article in our March 2012 update concerning the decision of the Swedish Medical Products Agency (the "MPA"

Publisher liability rejected by Philadelphia C.P. Court

  • Reed Smith LLP
  • -
  • USA
  • -
  • May 16 2013

Some time ago we were highly critical of a potentially dangerous expansion of liability for failure to warn to publishers of medical literature

AOD-9604: patents, peptides, performance and.cellulite?

  • Phillips Ormonde Fitzpatrick
  • -
  • Australia
  • -
  • May 14 2013

Australia is no stranger to sporting scandals. Cricket's "John the bookmaker" affair, horse racing's "Fine Cotton" scandal and any number of player

NAD recommends goodnighties discontinue claims regarding sleepwear

  • Winston & Strawn LLP
  • -
  • USA
  • -
  • April 29 2013

Following a challenge brought before the National Advertising Division ("NAD"), Goodnighties, Inc. has agreed to discontinue certain claims regarding

FDA knows time is running out on internet and social media guidance

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 29 2013

In a recent interview published by Pharmalot, the Director of the FDA Office of Prescription Drug Promotion (OPDP), Thomas Abrams, indicated that the

Brazilian regulator fines Mcdonald’s over Happy Meal promotion

  • Shook Hardy & Bacon LLP
  • -
  • Brazil
  • -
  • April 26 2013

The consumer regulatory agency of Sao Paulo, Brazil, has reportedly fined McDonald's US$1.6 million for allegedly marketing to children. Procon SP

FDA says that it knows that the clock is ticking on internet and social media guidance

  • Dechert LLP
  • -
  • USA
  • -
  • April 22 2013

Our readers know that we've been posting about the FDA's obligation to issue guidance on promotion of medical products using the Internet and social

Being proactive may reduce risk for corporate raiding and loss of sensitive company information

  • Fredrikson & Byron PA
  • -
  • USA
  • -
  • April 22 2013

It seems as though some industries are prone to non-compete and trade secrets litigation, and the medical device industry is one of them. Earlier

Could FDA be the next NFL commissioner? What happens when a medical device becomes part of the required uniform

  • Squire Sanders
  • -
  • USA
  • -
  • April 10 2013

Recently, the New York Times reported on a decision by the National Football League (NFL) to expand league-wide a 2012 pilot program involving the